Summary of Mount Sinai's New York BCI Symposium, by Synchron and Precision Neuroscience. Market Trends and forecast for brain ...

Clene's cash, cash equivalents and marketable securities totaled $14.6 million as of September 30, 2024, compared to $35.0 million as of December 31, 2023. Clene expects that its resources as of ...

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...

Q3 2024 Earnings Call Nov 08, 2024, 8:30 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants. Prepar ...

Q3 2024 Earnings Call Transcript November 11, 2024 9:00 AM ETCompany ParticipantsVivian Cervantes - IRNestor Jaramillo ...

Reported 100% of Acute Myeloid Leukemia (AML) patients treated in INB-100 remain in complete remission (CR) at the 2024 ...

On Thursday, the FDA proposed removing oral phenylephrine from the list of approved active ingredients for over-the-counter ...

Maj.-Gen. Zamani Lekwot released book on 1992 religious violence. (Christian Daily International-Morning Star News) ABUJA, ...

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results ...

Also in July 2024, Checkpoint completed a registered direct offering priced At-the-Market ... common stock, for total gross proceeds of approximately $12.0 million. In September 2024, Checkpoint ...